Lenzilumab Antibody is a research-grade biosimilar monoclonal antibody targeting Granulocyte-macrophage colony-stimulating factor. It is a human IgG1-kappa antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% as determined by SDS-PAGE. For research use only.
Granulocyte-macrophage colony-stimulating factor (Granulocyte-macrophage colony-stimulating factor,Sargramostim,GMCSF,CSF,Colony-stimulating factor,CSF2,GM-CSF,Molgramostin) is a ~16 kDa protein. Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.
Product Name:
Lenzilumab Antibody
SKU:
GXBS00058
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
Granulocyte-macrophage colony-stimulating factor
Isotype:
IgG1-kappa
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FACS, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
KB-003, 1229575-09-0
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
